Completed PHASE3 INTERVENTIONAL 1-arm NCT01285661

Optimal Duration of Anticoagulation in Deep Venous Thrombosis (MORGAGNI)

Identification of the Optimal Duration of Anticoagulation in Patients With Deep Venous Thrombosis of the Lower Extremities With the Use of Residual Vein Thrombosis in Combination With D-Dimer

Sponsor: University of Padova

Conditions Deep Vein Thrombosis of Lower Limb Lower Extremity Deep Venous Thrombosis Recurrent

Interventions Sodium warfarin

Updated 5 times since 2017 Last updated: Jul 17, 2016 Started: Mar 31, 2010 Primary completion: Oct 31, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01285661, this PHASE3 trial focuses on Deep Vein Thrombosis of Lower Limb and Lower Extremity Deep Venous Thrombosis Recurrent and remains completed. Sponsored by University of Padova, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Padova

Data source: University of Padova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Padua, Italy